TippingPoint Biosciences

TippingPoint Biosciences is a developer of a drug discovery platform designed to identify treatments for diseases caused by DNA packaging defects. The company's platform is capable of discovering novel drugs that target the specific packaged DNA states associated with particular diseases, including several cancers, enabling physicians to treat cancer and neurodegenerative diseases and provide stem cell therapies by targeting dysfunctional genomic packaging that leads to disease.